S1 Ep1: Precision Medicine

Most of us know a person impacted by cancer. Yet while cancer research has been going on for centuries, we still don’t have a cure. Two major advances, targeted therapy and immunotherapy, have led oncologists to the practice of precision medicine. On this episode, Joe talks to T.J. Sharpe, a cancer survivor and patient advocate. Hear what factors led him to research an alternative treatment plan for stage IV melanoma versus a standard treatment plan, which offered him only months to live. Joe also talks with two passionate Lilly scientists, Dr. Kim Blackwell and Dr. Levi Garraway, who lead the way in oncology research and development, specifically in the area of precision medicine.

Om Podcasten

The Elixir Factor podcast brings researchers together with industry leaders, advocacy groups, patients, and their loved ones to discuss how Lilly tackles the world’s most significant health challenges. Tune in as we unpack complex science and innovative breakthroughs that can make life better for people around the world.